# EDGAR Filing Document

**Accession Number:** 0000725363
**File Stem:** 0001654954-25-009072
**Filing Date:** 2025-8
**Character Count:** 2264
**Document Hash:** 5806cb34571dbe996a7c18c7d6a3b34c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-25-009072.hdr.sgml**: 20251211

**ACCESSION NUMBER**: 0001654954-25-009072

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250805

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CEL SCI CORP
- **CENTRAL INDEX KEY:** 0000725363
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 840916344
- **STATE OF INCORPORATION:** CO
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 8229 BOONE BLVD .
- **STREET 2:** SUITE 802
- **CITY:** VIENNA
- **STATE:** VA
- **ZIP:** 22182
- **BUSINESS PHONE:** 7035069460

**MAIL ADDRESS:**
- **STREET 1:** 8229 BOONE BLVD.
- **STREET 2:** SUITE 802
- **CITY:** VIENNA
- **STATE:** VA
- **ZIP:** 22182

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INTERLEUKIN 2 INC
- **DATE OF NAME CHANGE:** 19880317

***HART & HART, LLC***

ATTORNEYS AT LAW

1624 Washington Street

Denver, CO 80203

________ harttrinen@aol.com <br> (303) 839-0061 Fax: (303) 839-5414

August 5, 2025

Chris Edwards

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Re: CEL-SCI Corporation Registration Statement on Form S-3, Amendment No. 1 File No. 333-288515

This office represents CEL-SCI Corporation (the "Company"). Amendment No. 1 to the Company's Registration Statement on Form S-3 has been filed with the Commission. The following are the Company's responses to the comments received from the staff by letter dated July 15, 2025.

The numbers below correspond to the paragraph numbers in the staff's comment letter. The numbers under the "Page No." column indicated the page number of the Registration Statement where the responses to the staff's comments can be found.

1. Comment complied with. Cover Page

2. Comment complied with. Signature Page

3. Exhibit 5 – Legal Opinion has been added to the Exhibit Index. Exhibit Index

If you should have any questions concerning the foregoing, please do not hesitate to contact the undersigned.

Very Truly Yours,<br>HART & HART, LLC<br>*/s/ William T. Hart*<br>William T. Hart<br>

Cel-Sci Resp to SEC Comments on S-3 8-4-25